Targeting tumor angiogenesis with gene therapy

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Tumor angiogenesis, the formation of new blood vessels that feed tumors, is a key target for cancer gene therapy.
• Gene therapy offers a promising approach to inhibit tumor angiogenesis, particularly when administered systemically due to vascular accessibility.

Purpose of the Study:

• To review the current status of gene therapy targeting tumor angiogenesis.
• To discuss future directions and challenges in developing antiangiogenic gene therapy.

Main Methods:

• Review of preclinical studies on viral and nonviral gene-based therapies for antiangiogenic treatment.
• Analysis of the principles and potential of gene therapy in targeting tumor vasculature.

Main Results:

• Gene therapy targeting tumor angiogenesis has demonstrated proof of principle in preclinical models.
• Systemic administration of gene therapy vectors is a feasible approach for targeting tumor vasculature.

Conclusions:

• Antiangiogenic gene therapy holds significant potential for cancer treatment.
• Further development of vectors with reduced toxicity and enhanced in vivo transfection efficiency is crucial for clinical application.